Patient P-02396
Synthetic patientMETA-24 · Day 180 · 45–54 · F · baseline S06Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Deteriorating
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
21%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S06
- Day 13 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 13.
Primary contributors, last 14 days
- Toxicity+16
- Inflammatory activity+12
- Treatment adherence-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable79 min
stable · +2.4 vs previous 14 d
Sleep duration
Wearable7.3 h
stable · +0.1 vs previous 14 d
Energy level
Daily log5.7/10
stable · +0.0 vs previous 14 d
Steps
Wearable8,092
stable · +72 vs previous 14 d
GI burden
Companion24.3/100
improving · -3.9 vs previous 14 d
Adherence
Companion90.4 %
improving · +4.6 vs previous 14 d
Sleep quality
Wearable46.4/100
improving · +2.0 vs previous 14 d
Glucose, CGM daily mean
CGM136 mg/dL
stable · -1.4 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 66 from the failing basin, 23 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -3.8 next day on high-intake days · n 20
Would not help
- Keep caffeine lowGI +3.6 next day on high-intake days · n 20
- Keep alcohol lowGI +3.6 next day on high-intake days · n 24
- Keep histamine lowGI +3.4 next day on high-intake days · n 21
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.8supporter · 95%
- Caffeine+3.6detractor · 95%
- Alcohol+3.6detractor · 95%
- Histamine load+3.4detractor · 95%
- Ultra-processed food-1no signal · 23%
- Insoluble fibre-0.8no signal · 27%
- Dietary fat load+0.7no signal · 15%
- Simple carbohydrates-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓60
- DNAFUT2 non-secretor lowers mucosal fucosylation
- MicrobiomeAkkermansia low → thinner mucus layer
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Inflammatory signalling ↑35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 35 ms, trending down
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Poor metabolizerHigher exposure at standard dose
- GLP1R rs6923761 AAltered receptor sensitivity
Microbiome
Shannon diversity 4.3 · butyrate capacity 74/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 37 ms
- Sleep
- 7.0 h
- Steps
- 9,182
- Resting HR
- 65 bpm
Daily log: GI score 24, nutritional resilience 62, adherence 90.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.